Yazdan Yazdanpanah infectiologue franco-iranien
Yazdanpanah, Yazdan, 1965-...., médecin
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Yazdanpanah, Yazdan, 1965-
VIAF ID: 78805795 ( Personal )
Permalink: http://viaf.org/viaf/78805795
Preferred Forms
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Apport de la biopsie osseuse transcutanée dans le traitement de l'ostéite du pied diabétique |
|
| Contribution à l'étude des questions statistiques rencontrées dans l'analyse des données de cohorte de personnes vivant avec le VIH sous traitement antirétroviral dans un contexte de ressources limitées |
|
| Contribution to the study of statistical issues encountered in the analysis cohort of people living with HIV receiving antiretroviral therapy in resource-limited settings. |
|
| Contrôle génétique de la réponse à l'infection par des virus oncogènes en population endémique |
|
| Cost-effectiveness of immunization strategies against infectious diseases in France with three examples : tetanus, rabies, and cytomegalovirus maternal-fetal infections. |
|
| Coût-efficacité des stratégies vaccinales en France, exemple de trois pathologies infectieuses : le tétanos, la rage et les infections materno-fœtales à cytomégalovirus |
|
| Efficacité des nouveaux agents antirétroviraux chez les patients expérimentés infectés par le VIH-1 : revue systématique de la littérature et méta-analyse |
|
| Efficacité et coût-efficacité de différentes stratégies de traitements contre l'hépatite C chronique en Egypte : définition des meilleurs critères d'initiation de traitement |
|
| L’épidémiologie comme outil pour l’amélioration de la prévention de la rage humaine : implications locales et mondiales des données de prophylaxie post exposition, Institut Pasteur du Cambodge, 2003 - 2014. |
|
| Évaluation de la performance du différentiel de temps de pousse entre cathéter artériel et veineux pour permettre le diagnostic d’infection de cathéter chez les grands brûlés : étude observationnelle, rétrospective |
|
| Evaluation médico-économique en santé : Prophylaxie des infections opportunistes chez les patients infectés par le virus d'immunodéficience humaine (VIH) : coût-efficacité des statégies préconisées par les recommandations françaises |
|
| Facteurs de risque de l'accès tardif aux soins et de la perte de vue chez les patients infectés par le VIH suivis à Bruxelles et dans la région Nord Pas-de-Calais |
|
| Facteurs prédictifs de l'hyperlactatémie sous antirétroviraux |
|
| Facteurs pronostiques dans les méningoencéphalites herpétiques : causes d'introduction tardive d'acyclovir et impact de la charge virale dans le liquide céphalorachidien |
|
| Fighting factors associated with poor prognosis among HIV-infected adults on antiretroviral therapy in sub-Saharan Africa. |
|
| Hyperendémie d'infections invasives à méningocoque en Seine-Maritime |
|
| Importance des caractéristiques individuelles dans la rétention dans le soin, l'observance et l'allégement thérapeutique des personnes vivant avec le VIH |
|
| Importance of individual characteristics in retention in care, adherence and maintenance strategies for people living with HIV. |
|
| Incidence and risk factors for medical care interruption in two HIV-infected patients cohorts between 2010 and 2016 in Paris and Caen. |
|
| Investigations épidémiologiques, cliniques et thérapeutiques du chikungunya |
|
| maladies émergentes zika, ébola, chikungunya comprendre ces infections et les prévenir au quotidien |
|
| Medecine, H.I.V. and the death drive : psychopathological study based on an exploratory practice. |
|
| Médecine, SIDA et pulsion de mort : étude psychopathologique d'une clinique « nomade » |
|
| Méningo-encéphalite herpétique de l'adulte dans la région Nord-Pas de Calais : étude descriptive et recherche des facteurs prédictifs de mortalité |
|
| Modélisation dynamique de la transmission du virus de l'hépatite C chez les utilisateurs de drogues injectables : efficacité et coût-efficacité des interventions de réduction des risques et des traitements antiviraux |
|
| Modéliser la diffusion des infections nosocomiales : l'importance des données de réseaux au sein des établissements de soins |
|
| Multiscale modeling of the spread of resistant bacteria in healthcare settings. |
|
| Pas de titre traduit. |
|
| PERDUS DE VUE : MOTIFS D'ARRET DE SUIVI DES PORTEURS DU VIH : ETUDE CAS-TEMOINS ET RECHERCHE EN ETHIQUE CLINIQUE |
|
| Predicting and estimating the potential impact of multiple interventions on HIV incidence, Ndhiwa sub-county, Kenya. |
|
| Prédire et estimer l'impact d'un programme d'intervention sur l'incidence du VIH, district de Ndhiwa, Kenya |
|
| Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection |
|
| [Primary pulmonary toxoplasmosis in an immunocompetent patient]. |
|
| Prise en charge des patients co-infectés VIH-VHC ou VHB le b.a.-ba du VIH |
|
| Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms. |
|
| [Pulmonary hydatid cysts: chemotherapy as a complement to surgical treatment] |
|
| QUALITE DE VIE DANS LES MALADIES INFLAMMATOIRES CHRONIQUES DE L'INTESTIN : VALIDATION D'UN QUESTIONNAIRE ET PREMIERES DONNEES FRANCAISES |
|
| Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis. |
|
| Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. |
|
| Randomized placebo-controlled study of the safety, tolerability, antiviral activity, and pharmacokinetics of 10-day monotherapy with BMS-986001, a novel HIV NRTI, in treatment-experienced HIV-1-infected subjects. |
|
| Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors. |
|
| Reply |
|
| Report of a European Working Group on late presentation with HIV infection: recommendations and regional variation |
|
| Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen. |
|
| [Retrospective study of 106 cases of varicella in immunocompetent adults. Parameters associated with varicella pneumonia]. |
|
| Review and methodological analysis of trials currently testing treatment and prevention options for the novel coronavirus disease (COVID-19) globally. |
|
| Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa |
|
| Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. |
|
| Risk factors for syphilis infection in men who have sex with men: results of a case-control study in Lille, France. |
|
| Risk Factors of Chronic Kidney Disease in HIV-infected Patients |
|
| Safety and efficacy of exposure to bedaquiline-delamanid in MDR-TB: a case series from France and Latvia. |
|
| SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital |
|
| Scaling up antiretroviral therapy in South Africa: the impact of speed on survival |
|
| Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area. |
|
| Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis |
|
| Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients |
|
| Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study |
|
| Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141). |
|
| Silent Cerebral Small-Vessel Disease Twice as Prevalent in Middle-Aged Well-Controlled cART-Treated HIV-Infected Individuals Than HIV-Uninfected Individuals. |
|
| A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection |
|
| Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report |
|
| Skin and soft tissue infections due to Panton-Valentine leukocidin producing Staphylococcus aureus. |
|
| Spondylodiscitis and an aortic aneurysm due to Campylobacter coli. |
|
| Staphylococcus simulans as an authentic pathogenic agent of osteoarticular infections |
|
| Study of the viral diversity in patients included in the ANRS PRIMO CO6 Cohort at the time of primary HIV-1 infection. |
|
| Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives |
|
| Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort. |
|
| Syndrome de Fanconi lié au Tenofovir et récupération à l’arrêt du traitement : considérations physiologiques à propos d’un cas |
|
| T immune responses to SARS-CoV-2 : identification of the immunogenic region associated with protection against infection |
|
| Transcutaneous bone biopsy for the treatment of osteomyelitis of the foot in patients with diabetes. |
|
| Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris |
|
| Trends in condom use and risk behaviours after sexual exposure to HIV: a seven-year observational study |
|
| Troubles neurocognitifs |
|
| Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis. |
|
| [An update on measles]. |
|
| Vaccination and blood sampling acceptability during Ramadan fasting month: A cross-sectional study in Conakry, Guinea. |
|
| Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis. |
|
| [Varicella after Varivax® vaccine in a pregnant woman] |
|
| Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay. |
|
| Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use? |
|
| Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness. |
|
| What Is a Modest Public Health Impact? |
|
| [When to initiate antiretroviral therapy and what to start with?] |
|
| WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. |
|
| Zika virus infection during pregnancy |
|
| Zika virus infection: report of the first imported cases in a Paris travel centre |
|
| প্রত্যুত্তর |
|
